Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Natixis Advisors LLC

Natixis Advisors LLC increased its stake in Doximity, Inc. (NASDAQ:DOCS) by 12.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 35,882 shares of the company’s stock after acquiring an additional 4,067 shares during the quarter. Natixis Advisors LLC’s holdings in Doximity were worth $1,916,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Global Retirement Partners LLC raised its position in shares of Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after purchasing an additional 440 shares during the last quarter. UMB Bank n.a. raised its holdings in shares of Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after acquiring an additional 235 shares during the last quarter. Larson Financial Group LLC lifted its position in shares of Doximity by 49.4% in the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock valued at $40,000 after acquiring an additional 250 shares in the last quarter. Morse Asset Management Inc acquired a new stake in shares of Doximity in the third quarter worth approximately $46,000. Finally, IFP Advisors Inc increased its position in shares of Doximity by 344.1% during the fourth quarter. IFP Advisors Inc now owns 1,328 shares of the company’s stock worth $71,000 after purchasing an additional 1,029 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the company. Leerink Partnrs upgraded Doximity from a “hold” rating to a “strong-buy” rating in a report on Friday, February 7th. Piper Sandler upgraded shares of Doximity from a “neutral” rating to an “overweight” rating and boosted their price target for the stock from $31.00 to $78.00 in a research report on Friday, February 7th. KeyCorp cut their price objective on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a report on Wednesday, January 8th. Wells Fargo & Company restated an “equal weight” rating on shares of Doximity in a report on Friday, February 7th. Finally, Mizuho increased their price target on Doximity from $55.00 to $65.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Eleven investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $64.22.

Insider Transactions at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now owns 6,360 shares of the company’s stock, valued at approximately $366,463.20. This represents a 75.87 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 37.40% of the company’s stock.

Doximity Stock Performance

NASDAQ:DOCS opened at $66.39 on Tuesday. The stock has a market capitalization of $12.39 billion, a P/E ratio of 66.39, a PEG ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $85.21. The company has a 50 day moving average price of $64.76 and a 200 day moving average price of $53.85.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.